Use of ezh2 inhibitors for the treatment of aortic valvestenosis

Aortic valve stenosis (AS) also called also called Calcific aortic valve disease (CAVD), is the most frequent valvular heart disease in Europe and […]

Method to predict the risk of a cardiovascular event in a patient with

The present invention relates to cardiovascular event in a patient with type 2 diabetes. In a cross-sectional study population of 672 participants […]

Use of soluble trem-1 as a biomarker for assessing the risk of

Early diagnosis of cardiovascular diseases can potentially cure subjects and save innumerable lives. Diagnosis and treatment of subjects at early […]

Method to predict the risk of a cardiovascular event in a patient

The inventors have identified new peptide biomarkers related to methylglyoxal (MGO)- induced glycation of plasma albumin, as well as the most abundant […]

Use of tryptophan hydroxylase 1 (tph1) inhibitors for the treatment of

Tryptophan (Trp) is one of the nine essential amino acids supplied by the diet, whose metabolism appears as a key metabolic gatekeeper of intestinal […]

Use of the recombinant fibrinogen-like domain of angiopoietin-like 4

Ischemic heart diseases are leading causes of death and reduced life quality worldwide. Although revascularization strategies significantly reduce […]

Artificial vascular prostheses made with polyvinyl alcohol and method

The present invention pertains to artificial vascular prostheses for the repair of damaged or diseased blood vessels. There is currently a urgent and […]

Biallelic gene mutations for the diagnosis of neonatal systemic

The present invention relates to a method and kit for identifying a subject having or at risk of having or developing an isolated neonatal systemic […]

A gene signature for diagnosing stimulator of interferon genes

Gain-of-function mutations in STING1, that codes for the Stimulator of Interferon Gene (STING), result in a severe autoinflammatory disease termed […]

Methods for prognosis and monitoring pulmonaryhypertension

In the present invention, in Pulmonary Arterial Hypertension (PAH) patient/u2019s blood samples (EFFORT cohort), inventors results indicate that […]